Stuart Cobb, Ph.D., Chief Scientific Officer
Dr. Cobb brings more than 20 years of experience in translational neuroscience. He leads Neurogene’s scientific research, developing our scientific strategy to support our existing and growing gene therapy portfolio, as well as identifying novel technologies that complement our pipeline. In addition to his work at Neurogene, Dr. Cobb also leads a research team at the University of Edinburgh, where is he a Simons Fellow and Reader in Neuroscience. Dr. Cobb was previously a Caledonian Research Fellow and led an academic research laboratory at the University of Glasgow. His research has focused on developing novel genetic treatments for brain disorders based on a deep understanding of the molecular and cellular pathology. Dr. Cobb’s work has been published in leading journals and includes seminal work on the inherent reversibility of neurological features in neurodevelopmental disease. Dr. Cobb has a B.Sc. from the University of Glasgow and a Ph.D. in neuroscience from the University of Oxford, UK.